Suppr超能文献

未结合和结合型3,5-二碘甲状腺原氨酸的尿排泄

Urinary excretion of unconjugated and conjugated 3,5-diiodothyronine.

作者信息

Hommel E, Faber J, Kirkegaard C, Siersbaek-Nielsen K, Friis T

出版信息

Horm Metab Res. 1985 Feb;17(2):90-2. doi: 10.1055/s-2007-1013459.

Abstract

A radioimmunoassay for the estimation of 3,5-diiodothyronine (3,5-T2) in human urine has been established. The urinary excretion of both glucuronide and sulfate conjugates of 3,5-T2 were estimated after enzymatic deconjugation. In 19 healthy controls the median excretion of unconjugated 3,5-T2 was 276 pmol/d, whereas the median excretion of glucuronidated and sulfated 3,5-T2 in 7 healthy subjects was 448 and 451 pmol/d, respectively. The median excretion of 154 pmol/d in 9 hypothyroid patients did not differ from that found in controls. In contrast 12 patients with hyperthyroidism had an enhanced excretion, 1312 pmol/d (P less than 0.01). Compared with previous data on the daily degradation of 3,5-T2, it is concluded that approximately one-sixth of degradated 3,5-T2 is excreted in the urine.

摘要

已建立一种用于测定人尿中3,5 - 二碘甲状腺原氨酸(3,5 - T2)的放射免疫分析方法。在酶促去结合后,对3,5 - T2的葡糖醛酸和硫酸盐结合物的尿排泄量进行了估算。在19名健康对照者中,未结合的3,5 - T2的排泄中位数为276 pmol/d,而在7名健康受试者中,3,5 - T2葡糖醛酸化和硫酸化产物的排泄中位数分别为448和451 pmol/d。9名甲状腺功能减退患者的排泄中位数为154 pmol/d,与对照组无差异。相比之下,12名甲状腺功能亢进患者的排泄量增加,为1312 pmol/d(P<0.01)。与先前关于3,5 - T2每日降解的数据相比,得出的结论是,约六分之一降解的3,5 - T2经尿液排泄。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验